Statement, March 2021
South Centre Statement on World TB Day
Countries need to step up the response to tuberculosis and take all possible measures to expand access to treatment.
COVID-19
SC, WGBizHRs, HRW Session, 17 March 2021
Not Charity, But Rights: Universal and Equitable Access to Covid-19 Vaccines
Session at the Second United Nations South Asia Forum on Business and Human Rights organized by the UN Working Group on Business and Human Rights, South Centre, and Human Rights Watch
March 17 12–1:30pm CET/4:30–6pm IST
Policy Brief 89, March 2021
Competition Regulation in Healthcare in South Africa
By Hardin Ratshisusu
South Africa’s nascent competition regulatory regime is coming of age and has potential to address historical market concentration challenges previously enabled by the apartheid regime, prior to its dismantling in the 1990s. Many sectors of the economy are highly concentrated, including the private healthcare sector, with market outcomes that breed market failures, lack of competitiveness and high cost of care. Looking through competition in the healthcare sector it becomes evident that the market structure challenges do not only require domestic interventions, but also a global response to address some policy and regulatory gaps.
Policy Brief 88, March 2021
Need for Extension of the LDC Transition Period Under Article 66.1 of the TRIPS Agreement Until Graduation and Beyond
By Nirmalya Syam
Least developed country (LDC) Members of the World Trade Organization (WTO) have submitted a duly motivated request for the extension of the transition period under Article 66.1 of the WTO Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS), which exempts LDCs from implementing the obligations for protection and enforcement of intellectual property rights under the Agreement, in view of their vulnerabilities, special needs, economic, administrative and financial constraints, and the need for a sound and viable technological base. This request, submitted prior to the expiry of the current transition period on 1 July 2021, seeks a further extension for as long as those Members remain LDCs, and also for an additional period of 12 years after their graduation. This request is legitimate in view of the varied challenges that LDCs face, which have been aggravated through the reversal of development gains due to the public health and economic impact of the COVID-19 pandemic. These vulnerabilities will also continue to afflict the LDCs even after graduation, as recognized in several reports by different United Nations (UN) agencies as well as resolutions of the UN General Assembly. Therefore, WTO Members must display political will and translate global solidarity pledges into action and unconditionally support the request for extension of the transition period for LDCs under the TRIPS Agreement.
Submission on Strengthening United Nations Action in the Field of Human Rights, March 2021
Strengthening United Nations Action in the Field of Human Rights through the Promotion of International Cooperation
COVID-19 could be an opportunity for effective international cooperation for the achievement of the Sustainable Development Goals, taking Human Rights as its fundamental pillar, the South Centre notes in its submission for the United Nations Secretary-General’s report.
This contribution was sent to the Office of the High Commissioner on Human Rights (OHCHR) responding to its invitation, with the objective of providing inputs to the United Nations (UN) Secretary-General’s report on strengthening of UN action in the field of human rights through the promotion of international cooperation based on the principles of non-selectivity, impartiality and objectivity, to be presented to the General Assembly at its seventy-sixth session.
COVID-19 Compulsory Licenses Table, March 2021
Scope of Compulsory License and Government Use of Patented Medicines in the Context of the COVID-19 Pandemic
To meet public health needs, such as in the current COVID-19 emergency, governments can use compulsory licenses and government use as a tool for procurement and import of patented medicines.
These mechanisms are provided for in most laws worldwide. The WTO TRIPS Agreement, as reaffirmed by the Doha Declaration on TRIPS and Public Health, recognises the right of WTO members to grant compulsory licenses and their freedom to determine the grounds upon which such licenses may be granted (read our Call for Action on Intellectual Property and Trade Measures to Address the Covid-19 Crisis here).
The South Centre offers a guide for the issuance of compulsory licenses and government use, see here, aquí en español.
The table below provides information of instances of their use.
Research Paper 129, March 2021
The TRIPS waiver proposal: an urgent measure to expand access to the COVID-19 vaccines
by Henrique Zeferino de Menezes
Despite multilateral commitments and political statements of solidarity and cooperation to guarantee the availability and access to COVID-19 vaccines (and other relevant technologies for control and treatment), the scenario after the beginning of vaccination is marked by the deepening of vaccine nationalism, the concentration of inputs and vaccines production, and the uneven distribution of options of vaccine doses already approved for use. This pattern of production restrictions and unequal access will lead to an increase in international inequalities, leaving a large part of the world to have access to vaccines not until 2024. While advanced purchase agreements (APAs) among pharmaceutical companies and some developed countries are multiplying, the proposed mechanisms for voluntary licensing of technologies and the COVAX Facility do not achieve their goal of democratizing access to vaccines. In this sense, the current TRIPS (Agreement on Trade-Related Aspects of Intellectual Property Rights) waiver proposal seems to be the political and institutional response with the greatest potential to guarantee the scaling of the production of pharmaceutical inputs, allowing the adoption of a comprehensive strategy to ensure timely, sufficient, and affordable access to all technologies developed to fight COVID-19.
Statement, February 2021
STATEMENT OF THE CHAIRPERSON OF THE BOARD OF THE SOUTH CENTRE, H.E. MR. THABO MBEKI, TWENTY-FIRST MEETING OF THE COUNCIL OF REPRESENTATIVES OF THE MEMBER STATES OF THE SOUTH CENTRE, 11 FEBRUARY 2021
The unprecedented health, economic and social crisis that the world has faced since last year has severely hit our developing countries and undermined their efforts to achieve the Sustainable Development Goals. In some cases, the progress made over the last decade, particularly in reducing poverty, has been lost. The effects of this crisis have not been felt equally among all countries either. It has exacerbated the profound economic and social inequalities affecting the poorer countries and the most vulnerable…
SouthViews No. 213, 23 February 2021
Access to Medical Equipment in a Pandemic Situation: Importance of Localized Supply Chains and 3D Printing
By Muhammad Zaheer Abbas, PhD
The response to the COVID-19 crisis highlighted the weaknesses of the free trade system and failures of the traditional supply chains. Public health preparedness for future pandemics demands nation-states to increase their local production of medical supplies in order to reduce their dependence on third countries. Globally connected local production, enabled by digital fabrication tools, is arguably the best policy response to collaboratively address supply-chain vulnerabilities. 3D printing technology, which is the most prominent manifestation of digital fabrication ecosystems, can play a key role in enhancing the local production capacity in a time- and cost-efficient manner. This paper calls for an increased focus on local production and proposes a more systematic use of 3D printing capabilities to address shortages of critical medical equipment in a health emergency.
COVID-19 Compulsory Licenses Table, February 2021
Scope of Compulsory License and Government Use of Patented Medicines in the Context of the COVID-19 Pandemic
To meet public health needs, such as in the current COVID-19 emergency, governments can use compulsory licenses and government use as a tool for procurement and import of patented medicines.
These mechanisms are provided for in most laws worldwide. The WTO TRIPS Agreement, as reaffirmed by the Doha Declaration on TRIPS and Public Health, recognises the right of WTO members to grant compulsory licenses and their freedom to determine the grounds upon which such licenses may be granted (read our Call for Action on Intellectual Property and Trade Measures to Address the Covid-19 Crisis here).
The South Centre offers a guide for the issuance of compulsory licenses and government use, see here, aquí en español.
The table below provides information of instances of their use.
Climate Policy Brief 25, February 2021
The UNFCCC Virtual Regional Workshops on Gender and Climate Change 2020
By Mariama Williams
In the last week of November 2020, the United Nations Framework Convention on Climate Change (UNFCCC)’s Gender and Climate Team presented its hallmark Global Gender Event as part of the virtual United Nations (UN) Climate Dialogues 2020 (Climate Dialogues). The Climate Dialogues provided “a platform for Parties and other stakeholders to showcase progress made in 2020 and exchange views and ideas across the subsidiary bodies and COP agendas mandated for 2020”. They were held in lieu of the annual meeting of the Conference of the Parties (COP) previously slated to take place in the United Kingdom in December 2020. The virtual Global Gender Event held on November 26, 2020 occurred in two parts. Part 1, Acting on the gender and climate GAP: progress and reflections highlighted progress and reflections made at the regional workshops on gender and climate change held by the Gender team earlier in the year. Part 2, Women for Results: showcasing women’s leadership on climate change showcased women’s leadership on climate change including the five winning projects of the 2020 UN Global Climate Action Awards.
Tax Cooperation Policy Brief 13, February 2021
Making the UN Tax Committee more effective for developing countries
By Abdul Muheet Chowdhary
The United Nations Committee of Experts on International Cooperation in Tax Matters (UN Tax Committee) is an important and influential subsidiary body of the Economic and Social Council (ECOSOC) that shapes standards and guidelines on international taxation. These are the rules through which Multinational Enterprises (MNEs) are taxed. Its role post-COVID-19 has become even more important as countries struggle to raise revenue. Despite being under-resourced, it has produced valuable guidance, especially on the crucial question of the digital economy. As a new Membership of the Committee is about to be selected, this Policy Brief provides practical recommendations on how the Committee can be reformed to be made more effective, especially for the interests of developing countries.